A New Tablet Containing Two FDA-Approved Drugs In HIV-Infected Patients Who Have Not Received Prior Therapy

NCT00053638 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

345

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infection

Interventions

DRUG: efavirenz
DRUG: tenofovir
DRUG: abacavir/lamivudine

Sponsor

GlaxoSmithKline